Skip to main content
SpringerLink
Log in

Antipsychotic use in pregnancy: no major perinatal risk

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1549 p12; 803120308

References

  1. Vigod SN, et al. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015: h2298, No. 350, 13 May 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h2298

    Article  Google Scholar 

  2. Khalifeh H, et al. Safety of psychotropic drugs in pregnancy. BMJ 2015: h2660, No. 350, 13 May 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h2260

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antipsychotic use in pregnancy: no major perinatal risk. Reactions Weekly 1552, 9 (2015). https://doi.org/10.1007/s40278-015-0805-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-0805-5

Search

Navigation